Amendment No. 2 to Third Amended and Restated 10% Convertible NoteCell Source, Inc. • August 8th, 2023 • Pharmaceutical preparations
This Amendment No. 2 to Third Amended and Restated 10% Convertible Note effective June 18, 2021 between Cell Source, Inc. (the “Company”) and Darlene Soave (the “Lender”) is effective as of this 28th day of October 2022.
Amendment No. 3 to Third Amended and Restated 10% Convertible NoteCell Source, Inc. • August 8th, 2023 • Pharmaceutical preparations
This Amendment No. 3 to Third Amended and Restated 10% Convertible Note effective June 18, 2021 between Cell Source, Inc. (the “Company”) and Darlene Soave (the “Lender”) is effective as of this 28th day of April 2023.
Amendment No. 1 to 10% Convertible NoteConvertible Note • August 8th, 2023 • Cell Source, Inc. • Pharmaceutical preparations
This Amendment No. 1 to 10% Convertible Note effective March 10, 2022 between Cell Source, Inc. (the “Company”) and George Verstraete (the “Lender”) is effective as of this 10th day of March 2023.
Amendment No. 1 to Third Amended and Restated 10% Convertible NoteCell Source, Inc. • August 8th, 2023 • Pharmaceutical preparations
This Amendment No. 1 to Third Amended and Restated 10% Convertible Note effective June 18, 2021 between Cell Source, Inc. (the “Company”) and Darlene Soave (the “Lender”) is effective as of this 31st day of December 2021 except as otherwise provided below;
